Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . . . . 2 . . . . : . . . ] 286
batch____ bits E-value N 100.0% 1:286 MIHQQHMRNIAQWLQENGITRATVAPDWMSIPCGFMACDAQRVICRIDECRGWSAGLALAPVMFRAQLNEQDLPLSLTVVGIAPEKLSAWAGADAERLTVTALPAITTYGEPEGNLLTGPWQPRVSYRKQWARWRVMILPILLILVALAVERGVTLWSVSEQVAQSRTQAEEQFLTLFPEQKRIVNLRSQVTMALKKYRPQADDTRLLAELSAIASTLKSASLSDIEMRGFTFDQKRQILHLQLRAANFASFDKLRSVLATDYVVQQDALQKEGDAVSGGVTLRRK
1 UniRef50_Q089T9 General secretion pathway p... 220 6e-56 1 19.3% 2:286 113:401 -VAHEQMQIWLEWLHHAGLKVKRIVPDCLALPLEQCRWAasEYLIRTSEGSGVSMPKAWSAFALPKLLIAanDNESISVASYSDDIVFEGVDINNKPLDLPMMVLAKGILNAPINLLSGIYKPKHEYSKQLLTWKNAAIVVMIAIVLALANKGIAIHQLNNQTTELQAQSEMIFKQAVPGVNRIVNMRSQMGSELRSMQGQGGGAVFFEMLDGLKPAFS--KVPELKPNTLRYEANRNELRMQVTAKTYGQIDTFKELVSKDYLLEGGAMNSSEESVTSTLTLRNK
2 UniRef50_D0I3A2 General secretion pathway p... 207 4e-52 1 26.9% 1:286 109:399 VIEHKIMQRWMDALSDANLTVRRLVPDCLCLPLHEDSCSahRWLLRFGETEGGSVEDAWLPVWLQSLGQSRGEETLPTVFSYSPLPEGMGGNWQAEPCELVMLLLTQEAVKSRYNLLTGRYKPQSQIYKYLKPWRGAAIAAGLLVAVLGIEQVVNIYQMDAQAAQYRTQSEARVRALLPQNQRIPtmRRIVEAEVNRLSGAGSQSGIMVWMAEIGPLLDAA--PSIELDALRFDQNRDELRLNARGKDFGDFEKLREALSTTYNTELGQLSRDGQAVTGAFVLRRK
3 UniRef50_A1SR64 General secretion pathway p... 203 7e-51 1 19.9% 1:286 112:403 ICDKQKMYDWIDWLEKAQINCKQFIPEGLTLPLPEDgwlGEQWLIRETANIAWSCDHSMLNTILEslKNSADEDLVPRIESYSPVIEDSVAEWSSHDAMLPMELLAIGTKNNPVNFLTAEFKPVKEVSPYIKKWRIPAAAGVLLFIVSVLNIYSHTLQVQAETELIQQQVETIYSQAFPRESKLRYARikLDTMLKELQGSSVEFDFLTVLDDLSPAL--MSLKEFEISSLKFDSKKQELQLALTAPSFQAFETFAAELPEHLSAQQGALNNSKSGVSGVLTIRKK
4 UniRef50_A6FGY7 Hypothetical general secret... 201 2e-50 1 20.6% 1:286 112:404 VIAHDKMQQWQTWLADAELVCEQYIPDALTLPYNEAHWSagQWLIRQTPTQGLCIESELLTFVLAtyPEDEGVNNIPTVMSYSPLDALALDNWQQGQIELPMKLCAEGAIASRYNLLQGQYKVVREENVALKLWRGTAIAASLAMVMIFVNQFVTLNKLEQQQSALDNEIRQVYKTVFKPKKMRLnvKKQMQSRLNDLRGGGDNSGFLVMLSQLTPAFKQL--PGIKPISVRYDTKQATIRLQASAADFQVFDKLKSSLSTQFDVAQGTLSQRDGRVQGTLDIKGK
5 UniRef50_C9P1R4 General secretion pathway p... 201 3e-50 1 24.6% 2:286 117:408 -VDRAWLQAMLEQLQALGLDVKRVVPDVLALPVHEEGLSadQWLVRKGEYSGLSVDKDWLTWFCAswVKNQTEYLPLTAYTPLPepLSEQQSWQSMACPSLLVLLTEQVLTHKINLLTGPFKPKSSWNKYWLIWRKAVIAGLFLLVVLMTSYGLQVHKDTQLAQSYRDESERIFREIFPDKQRIPtlRRQMTDELTALSGSAQGEDVLSWFSRLPETI--GSVTDMQVQSLRFDGNRSEVRLDVTSSDFQSFEQARVKLAEYFLVEQGQLSRNEQRVSGSFVLKPK
6 UniRef50_Q5E1Y5 General secretion pathway p... 200 5e-50 1 23.4% 1:286 112:417 IIEHSKMTMWLEQLSDAGIQTKRFMPDVLALPFHDDGAsgQQWLIRHHEYQGAVAEPQWVSMLleSDEDAESSPMPFILHSYSeeMEIAGAKVNLESPELVMQLLAEGLLSSKVNVLNGPYRPQSSWRKHWRVWQKVILSLGLVMVAFVAQHVSEVQKLEQHSLALHAESERIFRDIFPNKRKIPTakSQMKNEEARLQGGAGGHDLLAWMAEISPYLS--KVPQVKLQSLKFDGKRNEIRLQASASDFPYFEKLTSELGTKFEVEQGQLNKNDGQVFGAIIIRRQ
7 UniRef50_P45782 General secretion pathway p... 196 8e-49 1 19.6% 2:286 117:407 -VDRLWLRACLDHLKACGFDVKRVLPDVLAIPRPEHGllGDEWLVRKSTTQGMAVDAQWLSLLAAswVQNEGEYLPLQALTPLPesLAETQEWRYEPSGLVMQLLTQEALTSKFNLLTGSFKLKSSWLRYWQIWRKVAIAAGLFVAVSISYSLFQAHQYEAQADAYRAESERIFRSIFPDKQKIPtlKRQMSDEMARLSGGASVGSVLKWLSPLPEALKGV---NLQLQSIKFDSNRSEIRLEATSRDFQSFEQARTQLEQYFAVEQGQLNKNGEQVFGVFVVKPK
8 UniRef50_Q47VE2 General secretion pathway p... 191 2e-47 1 17.8% 1:286 119:421 IVAHSQMQQWLSWLADADIETDTILPDVLAMPIVAEGWSaeQVIVRQKLWQGFNVDANAWQLQCqaEGNEQSHSILIEAYSPLAHSEQCNVSTMPEELALALMATNYDSKLSHFNLLQGQYKVKENRSHTGRQWLWVAGVAMFAILLSLGHKSAQLWQLNAEQENIQQNIVASYKKAFPKTkrISTIKSQLNRELALLGGVGDRQGFLAMLAKLQPAFA--KVPALKPESLKFDGKRQELRIQATAKDYQAFEQFSVALatNLIVKQGSQSNQGDQVTGSFSITNK
9 UniRef50_P31708 General secretion pathway p... 190 6e-47 1 17.1% 1:286 134:424 VVEKNRMQRWLAQCDALGLSVDTLLPDARVLPKHQDGWSALqwLFRQPTGHAMAAESSWCGDLLKASMPLPAIYSYSAASVGGELAQYEwgEWKAQPETDLFTLAATAHLPASVDLRQGDYAPDKAWQNTLLPWRGVGIAFACYLLLVVADAGWAHYQLYQQAEHWRQESVRVYRQIFPSETNVVNPRAQMQQHLQRTAAGGAGKALLDQLTPLQQLMTQ--NSAIKIQSLSYDGAAGEFRLALQGTSYQELEQFQQQAAAYYQVQAGEMRQENDRVEGRLTLRSQ
10 UniRef50_B4S158 General secretion pathway p... 188 2e-46 1 18.6% 1:285 111:397 IVSHEKMLQWQAWLSEAGLFCDTIIPDVLAVPATPNGWsgEQLLVRQDEFKGVQGEQAWLLPTLVHFTAQQEAPVTITNYAGIDLSSLPNIEEAQAPLELPMQVLAKEAMQSSFNLCQGEYKLKRKRSGVLSQWRVAAVLAVLALCTSLIDKGVTLYQLKSENQALSSEINAAVKAGFPNIGTYRNVRLKLQSELAKLEQGGGDASMLIMLDQLAPAFTATD---VKPQTLRFDASRTEIRIQAQGKNFEALEQFKRSAeaGFLVEQGAINNRDNGVVGTVSVRS-
11 UniRef50_Q5QY99 Type II secretory pathway, ... 180 4e-44 1 23.9% 1:284 113:398 VVAKERMNYWLQVLTEAGIDSAFWVPDCFLLPHQNDTwlADSVIVRTGEWQGFTIEKEQFAQLAPAFAAEQNSPTEIIHYGAL-NWPQSPAPLIPADIEVPFTIAVQSIagNRINLRQGAYRSQRAKRSVDLPWKGLATAASVLFVLAVLLNGVRYWQLESQRGALKAQAEQLYRDAFPGQTRIVNLKVQLQRQLESLggSADEASVLAVLQQLAPAFK--SQPELQLELLRFQNN--ELRLQATASSFSQFEAFQQAaaEGLTVEAGSMSNRGEQVSGSLTVQ--
12 UniRef50_C4L990 General secretion pathway p... 179 1e-43 1 22.5% 2:286 113:394 -VEQTQMQQWLSWLADAGLTAQQLLPDVLALPQPEGEqlGDQWLIRQSAWQGSVVDNDLFSAWM------TCHQPYPALHSYTPPPAEPPAEWIVSLCELPMQLLAEQVPVQRIDLLQGAFRRVSTWKKQWLRWRLPAVLTGLLLLLFMANQGMEYVQLRQQQQQLQQQMTALYRQLFPEEKRIVNPRAQLKQHLQGLQQAPLTDSFLSQLALLAPLL--HKTPEIELQQLRFEADKQEFRLQISAKDFGMLDKFRNQANTTFATEMTNMQDQGGRVSGMLIIRSK
13 UniRef50_D0Z0Q1 General secretion pathway p... 179 1e-43 1 23.9% 1:285 116:435 VVEHSKMAYWLEQFKQHHFEVRKLLPDSLCLPLFNDGYSaqQWLIRQSETLGINVEISWLDAWLSAqaAQDEDLSQVIIHHYTPAPEVQLGRWRAETPELVMQLLAQGAESSKLNLLSGAYKPQAAWRKHLLPWRKVAIAAGLVLTALVAEHVIAVNQMENQAQAYRTESERIFRQVLPQFKRisYLRNQMKRAVASM-GGEQQQGLLTWLLELQPMLKQ--VSQMQFTNFKYDQKRGELRIQANSTDFQHFEKLRTLLAKDFTVEQGQLSKEDGRVNGAFVLRR-
14 UniRef50_Q46833 Putative general secretion ... 178 2e-43 1 100.0% 1:286 1:286 MIHQQHMRNIAQWLQENGITRATVAPDWMSIPCGFMACDAQRVICRIDECRGWSAGLALAPVMFRAQLNEQDLPLSLTVVGIAPEKLSAWAGADAERLTVTALPAITTYGEPEGNLLTGPWQPRVSYRKQWARWRVMILPILLILVALAVERGVTLWSVSEQVAQSRTQAEEQFLTLFPEQKRIVNLRSQVTMALKKYRPQADDTRLLAELSAIASTLKSASLSDIEMRGFTFDQKRQILHLQLRAANFASFDKLRSVLATDYVVQQDALQKEGDAVSGGVTLRRK
15 UniRef50_C9NLJ3 General secretion pathway p... 176 6e-43 1 18.3% 2:285 113:403 -IDYSWLESILADMRQLGFAVRKVLPDALALPVAEEseLDGQWLVKKGQFSAVSIELAWLPLLAQswVKQEEEYLPLQAYSHLPEllADEQKWHNEQPQLVMQLLSEQAVKSKLNLLSGEFKPKSSFGRHLKVWRKAAIAAGVLVAILSVDNWLQIQSAETQANAYRQESERIFRQVTSKnpTVTYLKREMEREESRLSGGGSGDSVLEWMVKMPQVMKQ--VPGLRLTSFKYDSTRGEVRLQAQSNDFQTFEKARELMSGQFTVEQGQLSKSGTLVNGTFVLKR-
16 UniRef50_C4K3G0 Putative uncharacterized pr... 174 2e-42 1 19.6% 1:286 112:407 VIAHSYIQTCLDWLAHAGLQATRMIPDWLALPYQEGEITanDWLFREGTYQGFTLEQECLPILyqDQTRDSTLNQNIRSFSSPPEDSSFF--WQAGAVIPALTVLARGCLSPNITLLSGPYRQNRTIRMPLLKGAAAVCMAILCFvlSVIEKGLIFHRLTQEIKKTQIKAEQAYQALFLKPQKVVNLKAQFNALTNQMKSQPKVPHLMDFLAQIAIGIANMRIQPRDMhaLRYAREHHSLYLQIGVNHFSEFEQLRNGLSEKFTVEQGVLVQEKKRVNSTFTLKNK
17 UniRef50_A0YG41 General secretion pathway p... 173 8e-42 1 16.5% 1:284 127:422 IVSKKILERIIFELKSDGIEADQLESELHAIPIDAGSWsdRRWLVRSGNHEGFSLQPTIAGQALEILLESNDELPQHlvLSIIPERLQSAIDWKIANYWQVMSKGHTNHQKNAINLLQGQFAAKLPWKKWWQSWRTVAVLLIAVVIIQMGVRYTQLVVLDDRNIALRAAIEKQYRQAVP-KGALMDPERQLRRKVNALKGSAS-SNLMSMLVQIGPVLKATD--GISLQSLNYNEKQSEFRITILASGFDDVETVRANLEngLTAELTGSNADGNSTRARLRIR--
18 UniRef50_Q3ILN2 Putative general secretion ... 172 1e-41 1 18.0% 1:284 116:399 MTDREWFEAWLALFAEHNLSVYKILPDALLLPPADEdaLNNQWLFKQGPWRISAVETSWLNGYLTAMGN----PDVKHFSPATQFPETVNLQAQTSDYDLPLALFAKQLEHTKFNLRQGMYQLKKKSTLWWGYWKSAAIITSVALVASITIKAIELHQLNTQLELAKAQVIERYQKAFPGTkrPHLIKNQIKGALAKIQDTSD-AGFLELTTELVGVFSQ--VSNFTPETLRYDKKRNELRMRARAKDFQTFGKVKAILeqGLTVDQGSLSNDGDFVVGEIKLR--
19 UniRef50_P45789 General secretion pathway p... 170 5e-41 1 23.6% 2:276 119:388 -VDKEKMQIWLGWLQQAGLKSQQLLPDVLALPPAADGWSALqwLLRQGPCQGIVADESLLAML----LAAEADPVTIHSHTPLPAIPAA--NWLAADPELPMLLLAKGALNCQANLLQGPYRPQTEYSRYWLQWRKVAVVAGLLLLVALTQRGMHLYQLAEQDKALKAEIRQVYTRIFPGENRIVNVRSQMAQHLKLLGQTP-QDGVLLLLTELAPTFA--EVPGLKPQVLRFDAARGELRLQVTAPGFAEIERFRELAGKRFEVQQGEGAQHRGQ----------
20 UniRef50_UPI0000E10DE5 general secretion pathway p... 170 6e-41 1 18.0% 1:284 111:410 IVAHHTMRQWLDWLTTANLHCDIMLPDVLALPLAPVTAVedQVLLRDSAWSGFCGESDWVIPVVSSYFNAQSGPISLTQYTTDDAFSSHqvQTVTAELELPMHVLADGIATHSFnlCQGQYQQRKRSSGQWQYWRSVAAVAVIALTLGLIDKGLTISQLAAQNETLSNQIKADIQSGFPNIGTYRDARRAITQYVKRIDNMGSGSSAVDMLANLTSAFA---NSEIKAQSLKFNDDRSELRIQAQAKAFSDLETFKQQaaAGYTVEDGAINNRNNLVIGTLTIK--
21 UniRef50_P15751 General secretion pathway p... 169 9e-41 1 15.9% 1:283 116:393 VVGRGKMRAWQAWCDSLGLSVLALTPDVLALPHSPTGWSaeQWLFRCDTWGGMAVETVWLDQLLTHWQDLAP----IACYSPPPDIAAP---WQPLPAQDLLQLAAANPDARRICLRQGDFAAKRRRQPTPRRWRPVIVAALALLLLWSSNCLHDHLMLGQQADAAVQASRDFYRQWFQTEKNVVNPRLQMQQHLRQMKNAGARPALISRLGALQQIID--DTPGIRLRTLSFDAARNALQLEISAVSSQALEQFSQRARARFRVQTGEMKPRADGIEGRLTL---
22 UniRef50_A0YBF0 Type II secretory pathway, ... 166 8e-40 1 18.2% 1:285 117:445 VVSHAVLINWLDILHSVKLSPTRIISDVLCIPFHAGQldDKRVMMRSGQHSGLVLPIEDFGFLFASWIGQHSKQDAVSAKPvePEVVakVTAYHEPIAEILVSSYSNERLDRQLNLLQGGYAVSAAGKNDWSNWRSVISVVAIGLLSYLLLMAGSGWYFNGKGNSLDAEAVLLYQQLFPNERRIVSPKKQMQNHI-RLSGVGKNSDFLPILASLASTLAADSDekLIVDQLRFDGGSGELQIQLRSSSIEKLDQLKRNLEggLEVDINSAAEQDDYVMGRLVVRR-
23 UniRef50_B7RST7 General secretion pathway p... 164 3e-39 1 16.6% 1:283 107:395 VCSKENMNAYQSSLASYP-GVTQWLPEPLLLPWQGGEweGDRAIVRTGACEGFSVEREMLSLMLHALTLEGAAPTAIIVYGQDQETDAALVdvQWRQGDLYAAMLIAESPDPALNLRQGEWAVRLPLARWWQHWRVAAVLFGVAVLVHLFATGLDYRHLKQENLALRGAVQSSYRQAFP-KGAVVDAEKQLRRQLQTMTGSSEASGFVSLMARVGEVVATAD---GSIVSINYNDKSGEMRLNLLAADYEAVERIRTGIAegLQATLENSSAQGERVRARMRV---
24 UniRef50_O32574 W0030 n=15 Tax=Escherichia ... 163 5e-39 1 15.5% 7:284 1:276 ------MHRWLAYCGQLGVREVRLLPDVLMLPLATEGWSagQWLFRRDRYAGMTVELSWLTHFL-----SLTAPPVIESYSVPPVpgPKTTEWRNQPGRDLLQLVAEGDGYDGADLRQGEFARQGTWYARFRPWRYVAGALLACVFLAGSNAGLAHYRLWQQAQFWRYESVRVYQQLFPSEKAVKDPRRQMLRHLQQSTGN-NIPELGSVMRQLQQLLS--ETSTIRLQALAWDSSSQTLKIDLQAASFQALEHFQQIAGEKYLIQPGEIRQQPQGVESRLILR--
25 UniRef50_B8KIY8 General secretion pathway p... 155 2e-36 1 20.5% 1:283 107:395 MVDRASMLRWAEELGELA-SLVPWVPEPLLLPWSPGEwdSDSALLRYGRCLGTRIENALLPTLLETLAQESSPERVieTADLARLGPLGTPGIQWRKGGLAAALLLHDPATPAVNLLQGDFAPQLPYRRWWGQWRRIAALLLVALSIHLVGGWLDLQRLERENRVLRTEIQSVYREVNP-RGAVVDAQKQLLRQLDGLRGGATGTTFTGLLSPLAELFS--PPGSLVLASLSYSQRNAELRVNLLAANFADVESLRVAlaAGYAASLESSSRSGDRVRARLRV---
26 UniRef50_C4T0X3 General secretion pathway p... 151 3e-35 1 10.6% 2:275 91:359 -VEHKLMNQWLGWLKEANISAKIIMPDVLALPFSLGKFSanEWLIRNSQLSGFSISSEILAKILDSKFSSA----HINTFSSSGN---KAINWQSTQYCDVLRIMAENIDYCNANFLCGKYNHFPGIEMNGLTIFRTVLLCLILSAVVCLNYWFDRYKIARDIDVLNTVSQEFYANIFPVDNENRNNTGHFNDYIEHYRDIESNANFIDLFYMTSPVIDSIDS---NVNSVSFNKDAGVMSYNISADESNTVekLKEINNKLSGVVLNQVSNDSD-----------
27 UniRef50_Q2SFC4 Type II secretory pathway, ... 149 9e-35 1 13.7% 1:284 117:427 VIRRERMDRWFDAANALEFPLHGMYVDAQMCPGEEGAldGDEVLLFQPGLVCMRTHHENLLPYLerASSEEGEAPAWNIRVLTPEDQKDSLGVLLAQIEHVDGaqIESFSVPSfnLCQGPYAIksSGSSGIGKWWPVAAVAAGWFAIQVGLDLTQGFMYQKQADEYEQQMVKLYRSLYPNEKNVSSPKRQMEGKLRNASNTGGGGFLQLLGEAGYQLSVQPGKQNMGFNNLQFSNQRGELAVEVKAPSLDQLDRYKQALVqgYQVDIGSAIKEPSGVRGKITIK--
28 UniRef50_C8R0C2 General secretion pathway p... 148 2e-34 1 19.6% 1:285 106:409 VIARERLDYWLELCRQHGLAPAGMVPEMLAVPLAGPDAAGReaLVRTGPQDGFVLDRDSLAImmPGIGNEAKLEFYHEEEAPELPEELAVLLAGSHRVGDVFALLAETleKEALNLLQGDYRPQAHWEKHWRRWRLPGVLVLVLLLFYAGLGLLENQRLSRYHEQLHDEIIEVYRTTFPGAQRIVNPRAQMEHQLQTLRGAGGEsgFLPLLADSGPVLSGA--AGMQLRGLRYRA--GELDLELTISDLQALDELKAALEegLEVDIRTATTRDERVLARLQVRE-
29 UniRef50_B1JQA6 General secretion pathway p... 146 6e-34 1 10.7% 2:281 120:392 -IEHELINRWLFWLNINGISACCIMPDAFALPFFNSEWseSNWLVRNNEMSGFLVNSSVLENILM------LAEPTIKVNAFSPTDI-KWGNWQSLDYSDPVLIMAKTVSGNHVNLLSGKYKYAERIIVNNSVFLRVASWFFLLFLVMSLNGWYQGYKIVRDTGALSKVAQDFYADFLPPAYHGGDVNTSFNKYISDLDLKKNNVSFIKLLNAVS---YYTADENVDVRSFNFNYSDGEISFDIEGDD-DLINEMLNDKTNLFNARVEVIRSGEDKYNIKL-----
30 UniRef50_Q5ZUD0 General secretion pathway p... 145 1e-33 1 15.9% 1:283 109:378 VIDKQRMKKLIQVFDEHGIEFDAVTLDWFALASQELIISESELLINNEDFKGV-LSGDLAQTYlpHTPAHLFQDSKIPVASPASQNEEHSYTWISKRL----------IKSKPLNLCQGEIQHGKTTDWVKKGYLLVGGLCGFWLISILFVNWLSLHWLNRQIDEIDRQTAVIYREFFPDAKQVISPKFRISQLLGG-STAENQTRFWFILNQLSKAIKD---SGITVEQLRYQNK--TISITLVSSDFESLQKIENKLKqqLKVKQTQASTKDQQVVATLEL---
31 UniRef50_C5BM28 General secretion pathway p... 144 2e-33 1 18.9% 6:285 114:406 -----LIAEALEELTAQGLDVRTVAADYLCLRRLNNGVtaNRVVVRTGEYTGFAVETFLAPQVLAEQQTALDFTATISLVAEDETALAELRSWLPEVWTQENGPEISeaQAPSINMRSGAFSRQLPFKRWIELWKIPMIAVAAAYLIAVAITFAQYQVAKQEQRVLVDQMNDVYLQAVPN-GRRGDPEGALRALVKNLKGGAEPTNLMALINGVASTMK--SVAGITVSSFRYNSDQRELTLNIEAGSFEDLERLRSTveKGFVAELLRVEARGDKQSARMKVAE-
32 UniRef50_Q1N4H6 Type II secretory pathway, ... 142 1e-32 1 15.4% 1:285 82:364 VVNKQYM----DGLFEHQIQHAYYLP--LALPFDKnaVLNDQVLLRLSEFKAYSIQKEAVGLFLQRFKNEFESIQVFGDLDELIKLEMESENIEIHQKTLDDLNQLIQSSRPNHDLMSGPYKVtkKKNPKLDLLKTPLTLAAALFICAISINWIQAFQLDGKSEAVKNASKNYYEQLFPGESAGYGMKRMFRQKLEEGELVQNGETFTRLLSGIGNPISSMS--SLELLGLRYNQSKATLEIELNAPSIAELDKLKKSLEQqyTVEIAAANNQGGKIKGLLKVNK-
33 UniRef50_A3WP17 Type II secretory pathway, ... 141 2e-32 1 21.9% 1:283 115:398 VVRHSEMQQWQQWLAAAHLEADEWAVDYLMLPEPegVQIADDVLIRMARWDGLAVEQTLADAVVG--LKQSEYPQTNHVVAYSDIALNDSTLALEFANSELPMVAFAN-QRVSLDIRGQRYAPKRAKRTLEIRWQPLAWAAGIALAVTLASSWVKTAYLNHQAEQLQQQAEALYKETFPNQTRIVNLRAQMRQQLQSLgdDQAMPSALAMLDQLAPAFQQQ--PQLSLELLRYQD--GALRMQAVAQNFSQFEAFQNQAQqgFEVQQGALNNRGDGVAGTLTI---
34 UniRef50_C7R8F2 General secretion pathway p... 139 8e-32 1 12.0% 1:283 113:407 VIDKAYLSSVLERLKEAAIEPDFAVSDAACLPLFEDAWtdDSVLVRQSANEYWSTEVDMLEDLvtQFEENQTVSQAARIYSPDEQSElaGLAIQKMSVDNSLEWLCSQFDNSSINLLQQEFSSQKKSQMNLGQWKLPTIAASVLIGVGIIYMISQMIVLGQQRANLKQQMLVSVQEVFPNINDVNTGLIQVSNRFSTLGGDAASSNSFMLL--FDRSLAAINPKEIKVSQLEYLSSQAQLSFDVEAASYTTLTGAQNKLesGMQVEMRNASENGGVWSARISV---
35 UniRef50_Q21EQ2 General secretion pathway L... 139 8e-32 1 14.0% 8:286 117:409 -------AGAIASLEEVNCDIQRILPDYLHlpVGAILVLDEGVlcRTSDNDGFAIDESAAPIVVSQLKHEYDFTGVIELVAETEELAEAMKSWLPAKWLDENGPEIRLREgpTFNMRRGRFARQLPIMRWVKDWKVPGYVAAAAFVLAMAAVSLEYFQAKAQFDRVRSEIFAVYKQVAPN-GRSSDPVRAMESMVKGQGGKSEPTNVMMLIDSTAKALK--NTPEVNLTSMRYSGDQKELRVNLETKNFSDLETLRTAIAkgLAAELLRVSAQGEIQQASMSVAEE
36 UniRef50_A1WZN9 General secretion pathway p... 139 1e-31 1 15.0% 1:286 108:407 VVEHAAMQAWLDEFASLGLEVDALVPENGLLPADSGHwdRNQVVLALGA-DGFALEPASAPVTLEAALAVAERPPQRLTLQAPAaePAPELESRAVDADLLPRLAAWYHPRTAVDLRQGPYARRERWGWLWRPLRPAAALLAVWLLGQGALQWLEVQRLEREAEQLTAEIEQVYRETFP-EGRVVNPRVQMEHHLRTIRGDRGGEGGGHLARLLGKAAPALAGDGLRVRTLRLRD--GSLEVELDTVDIETLEGLRRALeaGLAVEIRSASAREGRVDGRLVIREE
37 UniRef50_Q31J19 Type II secretion pathway p... 137 5e-31 1 17.0% 1:283 106:365 IVSNERMTQWVDALTSAGLANAQLVPDCFQCPIPEEHntDTHRLARTGKWTGMAIPHDWLTLafKHMTWQQEAPSFQVMEHFKP-----------------------------FGLRQGKYQPFSKSTAWAKNWAKVIGVFGALLVLLVTQNWMEAHQKTIEKQQLTEATERLFKQMFPEVKRIVNLTAQAKTALDQQPSEVAGVGPAQLAKAVEPAFKQ--VPKVEIKAFKWQNKR--LSLSLESPDNDSLQALAGALKNKVTLTLKINSMQPNQIQAEMVI---
38 UniRef50_Q8GBD8 Yts1L protein n=5 Tax=Yersi... 136 8e-31 1 12.9% 2:273 122:384 -IDKNQLEQWLGWLRSAGLSASRALPDVLALPVPTGGWTAArwLMRQSVDQGFSADDEELGFILGRYPTL----PAILSYSQRPENEPTWLQKNVQPIWP---LLAQGAQKNSINLLHGDFTPPRTAKV--RGNKLLVALAAVYLLTFVTEPTLSGYYAQQHAEQIQQKTQQLYLKNFPGATPPKQWIQGIAQQIHQLEKDITPPGLLSQLRAAMPILQSLT--GVKTQAMEWQSETLALTFNLAEPEL--LARIPRQNANKLNITTHPMDQQ-------------
39 UniRef50_A1U0C5 General secretion pathway p... 134 4e-30 1 17.0% 2:284 122:433 -IDREQMARWRQLFSGwhARLEAVYPDASLLPAAESGwdAESALLQsgEWLRMQADnpLLAVTLAAPSSDEVVAEIPVQLYGTEADLDASQALVSELSGTTGLLRIEKKpsQPINLCQGAFAFKAEGSSPLKPWKPLIAVASLWFVIQMGLEIGMGIYQQQQAEQLESQAMAVYRNAFPSDRraGNVRRVIEGQLRVAGSQGSDVDFITLMKYTGDQYGRLQNPgvTFNSINYSRSRGELVVDIRADSYDRLSRLRNGLaeGLQAQIGSVVNESSGARGRLTVS--
40 UniRef50_A4A5K5 General secretion pathway L... 133 7e-30 1 18.4% 1:283 105:393 MVDKQLMHHWETQLDVFARQV-PWIPEPLLLPWSAGEWtaETTLLRYGLQEGTRVENSLLPALLGALRDDAPPERVLvaVGENILAALEDLDLQWRRGGLEEALLLSEDGRSQLNLLQGEFAPQLPYGRWWREWRAIAALLLLALSVHLASGWLDLKRLQRENLVLRQEIETVYRGINP-RGAIVDAEKQLRRQLDGLRGGATGGTFTGLLAPLGAALSPQEDT--VLASLSYSQRNAELRVNLLTANFAEVESLRGSlaAGLSASLESSSRSGDRVRARLRI---
41 UniRef50_C6XJ55 General secretion pathway L... 133 9e-30 1 14.5% 1:283 108:385 VITNEKMVYWSDTVKRAGLVATKIVPDYFCLPIEDaaNLVDRSVFRYGHWGAcgFDSKLLDKIIASGVSQNDNIAELDQLSYRDF---------SEGGVDPLDVLAVQAVKEKFSLQQGQfaRNLGGKLDLKEWRLPVGLAAAAILAMAAFNFVEGIAFNREAKALQATIEADVKRVFPDVKRIVNPKAQ----LKTLTSGNGEASAFLQLSGLIST-GINDVDGISLDALRYDARRREIQASIVYEDYEQLTQFREIIEngGTFREGGSRQIGNRRAGEITV---
42 UniRef50_B8GU52 General secretion pathway p... 133 9e-30 1 18.2% 1:285 108:409 VVSRAQMDQWREQLREAGLDPRSLVPETALLPTHGEGweHDSAWLSTGPGEGMALDRDNAALLVRLRLEETDEEARPGHLEVVRHGPARDTdwRDSEATLLEEIAQQLPAKLPFNLLTGPYSRREQLGRLWRPWRAAAAVLAAWALIQVALVVVDIQRLERERAALDAQMREIYETAVPGSRAGGDPRRQMESALAGRGREAGAAGAGDLGEALAHTATVLtlSGLSIQSLRYRPGQMELDLQL--DSLQSLDRLKQELEAdwAVEIQSASARDDGVESRIQIRR-
43 UniRef50_A1JPG7 General secretion pathway p... 132 1e-29 1 12.4% 2:259 120:371 -VEHELMSRWLGWLTNVGVSPTVMIPDVLALPFNDGRclDDEWLIRNSEVSGFSVNDDIFKKLCLSTLIFCPENRFSRVYNQT-------SGLHATDYCDVLRIMANNIENNHVNLLTGRYYRHRKKTISSASFFRSVYLFFLLSIVMCLNSWCYKNDILRDIHMLD-VTLQGFHIKYPLVQQYADEDSivNKDFYHSDGNIIKPDLIFLLHGLVENFDRLD---ITIKSIIFTNEKNKSSFNVRVINVDGIDQVLNKI---------------------------
44 UniRef50_A0Z782 Type II secretory pathway, ... 131 2e-29 1 12.8% 3:283 101:384 --SQADMGSWLESLGDD--FEGAFVHEALFLPWQPGEveTRSVLLRWGQHQGARVEHDLLAPLLNALPTAADAVIVYGRdaLLPDVLRELAQWRQGHFGT--ALMLVDRGQKFIDMRQGAFAPSLPFKRWWQSWKPLAIALIIGAVLQVASDLAQYWRLKDDNIALRAAIEESYRQANP-RGSLVDAEKQLDRQIAEYAVGVKGLIFTEILDRVGRVIAVSS--ELTLSSINYSDSAGEVRLDLLAPNYDEIEALRErtTSGLNATLETSSQRDTQVRARLKV---
45 UniRef50_B3PF10 General secretion pathway p... 129 7e-29 1 14.4% 2:286 116:424 -TDKNWLHMVFAELASLGLEITRCWSAPMTLPlaPDQAIAEHWTlrHNAYQGFSASSSYAPLALQLLLneSSDLPALHLRAASEAELDSLRGLLPSMLQGQIASqaLDFGTNTIDLCQADFSQRLPVERWWKLWKSVAIFAGVCLLVYFSTALFEIRKLGKENLAIRQDIEAAARLAIPQ-GRIVDAEKQLTGLLRQMEPAQASGSVMTLLAKTLPQIAALS--SVQIKGVAYSSETGELNINIQADSFSTFETLSSNiaQGLAAELLSANVQGNVQTARLKVSKQ
46 UniRef50_A8AIN0 Putative uncharacterized pr... 129 8e-29 1 15.1% 2:273 108:369 -IDATCFERWLALCEEAGLKVIQVLPDAILLPVNEGGStdESWWLRFPPFGACEADATLLPLLLA-----QGGDGEVCCYGEAPAGIDVVEQLPWQHPLVLIQP---QWKACRANMLHGAFAACGKEVGRFRHLRTAMAVSALlmGLLIGPRVAMAWMLVQQENQVQAEIAQVAQHYFPSLRQKTNIKYHFGQNIKKQSKG-----IFLQLEALEQVKQ--SVPAIEINEVEYDNAQNVLTLNAASPNAQALQDFVTQASPHFDFALQPVSNQ-------------
47 UniRef50_C4RZJ2 General secretion pathway p... 128 2e-28 1 11.4% 2:246 91:329 -VEHSLIKVWLGWLQNAGIYTEIIMPDVLILPFNPGEwlGNEWLIRDHEFSGFSIQEAVLKKLVLSRFISISKDLFSTSNDKP-------IDHHLVSYCDVLRIMSENIENCSANFLRGKYAFCHNQGSKSNYNFKFIWLLFLLSTLICSDYLIENYKIGKSIDALTFMSDDFHNDFFWNNKVGTTEIIDFSYYTYSYNRRVMNFNLISLLHDSSHIINDLD---LSINSIYLDNERQTISFNVTT----------------------------------------
48 UniRef50_B8KQM0 General secretion pathway p... 128 2e-28 1 17.4% 20:283 142:410 -------------------RLRRWLPEPLLLPWQAGEWteDSVLLRIAEYQGTRIEYELLPALLRALPPPESGLIAyrALQAIPDELRAMVQWRQGGFGD--ALLVADIGPATLNLRQGRYAPRLPLQRWWGEWRWVAMAAGAALLLQLGSDLVIGQRLKHENQALRAAIESSYRQANP-RGAMVDAEKQLDRQLAEFQSSDVSGAFTPTLAAITSVLAQET--GITLANLSFSGRQGQVRVNLLAPDFSAVERLRSAMSqgYQTTLESSSAAETRVRARLRI---
49 UniRef50_A4VFT8 General secretion pathway p... 127 4e-28 1 19.9% 2:283 38:308 -IRRQLLAGWLEQLRELGLLIVAIHVDADLLPRE-----ATQLLFIGERGLLGGEGETRLAFATVDWPQLATLCPAPWHAQGNVAEPPLALDDYRQLDDPYAFLAAQ--RSAALNLAQGDFAVEVG-NTGLGYWKPLFAVAGLILLVQLGFNLGQAWYFQRQGDAYAEASLALYRELFPEDIRIVNMRAQFDDHLAR--GSGGQAGFLRLLDHAAAALEDGIP--VTIGQLDYNQDRGDLALQVQAMDFATLETLRRRLgaRQSVQLGSASREGDGVSARVVI---
50 UniRef50_P45763 Probable general secretion ... 127 6e-28 1 15.8% 2:285 112:384 -IQSEKLSRYLERLHTAGLNVTRVLPDGCYLPWEVDSWtqTSWLIRSAAHAFNELDEHWLQHLAAQFP-----PENMLCYGVVPHGVAAANPLIQHPEIPSLSLYSADIAFQRYDMLHGIFRKQKTVSKSGKWlrLAVSCLVLAILSFVGSRSIALWHTLKIEDQLQQQQQETWQRYFPQIKRTHNFRFYFKQQLAQQYPEAVPL-------LYHLQTLLLEHPELQLMEANYSQKQKSLTLKMSAKSEANIDRFCELTQSWLPME----KTEKDPVSGVWTVRN-
51 UniRef50_C4U9B7 General secretion pathway p... 126 7e-28 1 11.1% 1:280 107:371 IVEHELMELWLYLLRTNGVIIESLIPDVLILPFINGEWSaeEWIVRNNEVSGFLVSDELFEKIYSFWYSSTLVNIMNDCD-------VKNVNWRVIRNKDPLHFMAKDIQSCNSSLLTGKYKFHDGAGITHRYISRVTGWGVLLSLIICLNTWHDGYKIAQATDMLDVYSNFYYSQ-FP----IVN-------ESGDLSRNESSVDFINLLSYLLGYFDDKD---LDIVSFHFSKEDKAIFFDVDRIDPsdFPEWAGNENEKIKISQSYNESGKDRVIFK------
52 UniRef50_C6P583 General secretion pathway L... 126 1e-27 1 13.8% 2:284 107:397 -VNKDWLSRFLAASTAARIRVRRIVPEFCLLPTRTnaWDGAQGFLATADHLGGMLDseVRAPAALQLRLQQGAPAALRLFALGSEIRQPDWGIKVPVikQSFDWRKADIPADAPNLLWGKFAPPPRISELWPWLRPALMAALLLFGVEVAVSNVEWAMLAHEKRQLMNGMTETFRETFGADAVIVDAPLQMRRNVARLrgVGDDADFSPLLEKLSGVLDA--VPGSTLRTLRY--GEGKLDIEMALASASALDTLLQRIAagLTAQVLDKRDSGGVLNIQLRIS--
53 UniRef50_A3YCA7 General secretion pathway p... 125 2e-27 1 15.0% 1:286 124:429 IVDKQVMASWLdwLQVIVLPVNSLIPFWPEQDTEADFLFTSDLNLLYKDQDSVSCLPKQGANYLPKREkdQAEVDGFGALAASFEILSPWSNQSVnwLYIVATRVQSNSKCLLANLCHGEFGRQTQFFSQLKPWLWVGVFAVFSLAVELYLTHQQTQALNAKADDIYQKTSTAFLKLAPDEGRISYLDRQIKGRIQRaqGDAKTQKGLTVYEVMALVDQVREQVSGEHRITKFDFANKEYRLDWQAGQRDTLDSIQTALEKkfQVVFEQVAKRGEVYVASIKLKEE
54 UniRef50_C4UYF5 General secretion pathway p... 118 2e-25 1 11.4% 2:255 99:344 -VEHKFMQLWLGWLKDAGISTTVIIPDVLTLPFSNGQWTsnEYLIRNNYFSGFLVKDTIVEKLLLTKSHLLSEDVFICTNSQPE-------NLQRGQSCDALRIMANNVNDSDVNLLCGRYYRYRKRVADNYFSFTRISILLLLFVVVFINSLFNKYEIENDINIL-NELSRGFYAKFPSVE-------QYDSYSQNDNGYpdRYNFIMYLHDSNTAMVNINSA---INSIRFDNKNRTlnLDITNSNVTdfDQI-------------------------------
55 UniRef50_P25060 General secretion pathway p... 117 4e-25 1 19.5% 2:283 108:380 -VQRTWLAAWLALAEGAGKAPASLHVDADCLPGEGScwLEERWLLGGSGAVRLACGSEDWPVLRDSCPPPQRAFAAQEVAPLEGVEVQAL--AGNPHVWLSEQPL-------GTDLAQAEFA-ARQQSSQWRRWRPLLGLVGLWLVLQWGFTLVQAWQLQREGDRYAAQSAELYRQLFPEDRKLINLRAQFDQHLADSASSGGEGQLLGLLGQAATVIGGE--PTVSVEQLDFSAARGDVALQVRAPGFDVLERLRSRLSegLAVQLGSASRDGSTVSARLVI---
56 UniRef50_B5JVC6 General secretion pathway p... 116 7e-25 1 14.8% 1:284 103:396 VCERRLMDAVVASLIEANLPVDALRTDVQALPMPQEAalREDDVCLHGAHGSVHCTRAELPIFLQQLYREQSDDehLSVFHAAGDVPDWPVFVEIDQQETVEEllLSRGAASGVNLLQGEFVIKSQSSGSLQRWQVPAVLAVVVLLVWLGSMFYQAYQYKQENQRLRDDIIAMYQSVAPGAQvvMTVKRQMQNRLDRLEQGGdtDASLKRLNRLASALQDQDLTQGLS---RVSLNRDALDFELVAENLESIETLRQALEqgAQADILSAPSQDGEVRAELRMK--
57 UniRef50_B2VI00 General secretion pathway p... 114 4e-24 1 14.7% 2:286 108:354 -VDPPRLQAALDAVKQRGFTPDYALPDVLMLPHGQAFRLDEQWLARTEPFSGVSVAVADLPLLAAQDSALCERVKEH---------------------ETCGRLTAEAEKISLPSLLHGGFSPAVNWRNGLRSLTAALFLSGCCLS---AIPLYHGWQLNLAADRFREQTLQHYQHYFPQE-RPAKPAQALLAHIHQKETHKPTAGLLVLLTECSALLS--NIKEIPLQTLEWDAKRQQLSL--------HFAKVIPADNELITPEGYQLARQGD---SSIIISRK
58 UniRef50_Q0A612 General secretion pathway p... 113 5e-24 1 24.5% 1:286 110:422 VIDRERMATWLHWAAEQGLELHTITPLELAIGAGDDDWrdQAGWLSTGPRAGLALEADAWPLILPRLLAqaPAGLALHPAGAAPGQVEALRAALPDTLTVSEQPAADSppHQAINLLQGPFSGREQWLRRLRPWRAVAALALAWVGLQFVMLYAEVRNLERTEQALRAETVEIFRDTFPD-SRVVNPRVQMERALAELdpERRSDPFIAVLNAVAPALTGDDAP--RLRSLAFRQQR--LELDLDAASVQALERLREAVEArwQVQIHSAASRGERIAGRVTIQRE
59 UniRef50_A8GJP7 General secretion pathway L... 111 2e-23 1 13.6% 3:274 113:356 --RHVDMQRWLSQLERWGIVPDSLLPDTLCGPVNDRHFYRWrlLRRTSPWSGYSLPSQWLL------------------------APSDVVDAVPLSPCDVLWDRVRGEAETAVSLLQGKYKAPPRWQRnwRHWPSIAGAALTLCALAIGGA-----HYHHQAKQANQQRDALYQRLFVGQPIPAEPVSESARYIRALQEAKSPRQFFELAAQAQRALQG--IPKHRVIGLTFDADRSMLAIRLQAPELQPFTQI-NDEGNTLELQVNPAKQQG------------
60 UniRef50_B8FE40 Fimbrial assembly family pr... 111 3e-23 1 10.1% 50:286 233:476 -------------------------------------------------CAGAGMNWENLQDAVQEQTGLPLKEINLTRDLQLPMEGRVAGNWDSSAMDGALALAlhPTETTGFNMRQGPFAVRRRWEQYKGWVIHVSILLAILLAAFGVRYFANKSVQEAKIASLKSQIEEVYQSAMEGRASSGDPLAAMMSEMEALSQapGAEGANVQVVDVLKAISDGIPPALNVKITSFSVNPERVEINGETDAYESATEIKTGLERQpdVSLQSVTAGKDPGVWKFRIKAQ
61 UniRef50_Q2Y7T3 General secretion pathway L... 111 3e-23 1 15.6% 2:283 91:401 -VDKKRLTQCLDALQAAAIQVDEIYCETLLLPWTPgaWEGREGFVRTGEFEGGATdpLSLHLMLEDAERHGARPASIALYTIEPEGAMTFEESAGEIMKNPAAApwRGAQQSSISLLQ-KHRRWPPFRGLLSRLRPAVWIGAAALVLHSLAVAADWALLANEERALHQQMETRFRALFPAAVAVVDPALQMRRKlrHAAGVPDTADFLPMIKTVGPALS--ELASGSLHAISYDSGRIALEL---AAEEGLANRIAARleNDLSVDINPAPTDGGAGIVVLVV---
62 UniRef50_A3UEX0 Hypothetical general secret... 111 3e-23 1 15.5% 2:284 113:426 -VDRDQLKTWREMLASLDAPQHHTVPDGMVLTGHGGDLtgDRVVfrSGDLGALSDSQDGARDLDAALSDPVCGAIEPHLLTppEGKPIAVKRIDAPDLRIAAASLPPEALDALPAIFGDAFATKLDWAALLKPWRAAAVLGLTAVLAASGLMVGQAAYLQDRASRYQAAQEAEFRMLFP-EARIVNVSAQMRQALNSVSGGasGAGFLPLATVLSETLS--DVDGVRVDSLRYDASRGELSVTALYSGFGDFERLRMAAEARGAveDGGARQSAAGVAGEFIVR--
63 UniRef50_B7GZW5 General secretion pathway p... 111 4e-23 1 17.3% 2:284 97:374 -VAQGMVETWQHSLALLPTKLVALLPDFLVLPEPQAqnIDHQLLVRENKWLGNSIDD--LGLFLEFQSAETHYQYSGLTAEQLESLEAASSAEQRSEFVYQFQPLDKTKQHP-FNVLP---KSKGQERTFSNYWKACAAVVLAIIVVQFSYDLLRWVKLKKVADQTAEQAIEQYKYWFGPSSRVtnIKGQFESHLRMSQQG--DTQALSLLSRVGPILMQR---QILAQQLNYDAS--ILTMALKAKSADDLQALTQQLnqGFKAELGNVQADGSGAIGVVKIQ--
64 UniRef50_Q3KBD9 Putative general secretion ... 110 5e-23 1 16.7% 11:261 113:346 ----------LQHLGQFGLNLKGLYPAAYSLPVMSGglHDDHLLLRHGQSSA-----QVQPMIDEAWLLETGLPAHWIGDGAPEAVQSTLADTQ-----------RCSGPLPNWGLHGGIQQPGTEHRG----WGRALGCCALALAVWVIGLNLYAAREAGQGQQLKAQMAQRVKQAFPELPVILNPLQQARQQIAARQQGAVDAPGQDFTRLVSQAGSGMPSMAGTVQRLEFVDGALQLSLLPEARRSGNDKGWQDTLAQ-------------------------
65 UniRef50_D2TMH0 Putative T2SS protein L n=1... 106 1e-21 1 15.8% 2:286 109:374 -VEPAVMQTLMLPLTAGGIRPDHVTLDALCLPITTDGwdEEGWLLKPHEGRASRLSEEWLDHLLTHY-----RPQQITSYGELPEAHTADTSCSPRP------LLSLYSPTESVNLLHGRLRPSAPATAGIRRLKRLALIAVLMLLLCPLLsaIVGFQLHRLEQQLTSTLEQRWRSYIPQNRHRGNLQAYLPKQLQQRFPAPS-----ILLQRLGQGMAA--FPALALEGIRYDQQRQSLQLFIYASDEDQIKQFITADAVGLPLKIEKHDQ------GLWTLRNE
66 UniRef50_Q0C119 General secretion pathway p... 106 1e-21 1 14.1% 1:283 102:363 VVDRSLMKSWIDLLTKAGLAPEKILSecLFTDIDHPVNLGDRIIQREG-NRIVGIDAALPQQARDALSAPTLEP-------------------SLEDGLHLIRLAERSTTRPAVNLRTGPFTLTKSAKQGVSAWRKAAGIAIAAASVWTGTLILEARNYNHAKEVTEKRAAERYTALFPVAAIPTNMD-QATREMLAVAATPDTLDFRTSVAALYEAVAQSTNTQIT--ALKFEGTDNRLTVDLSSPSPEALGAIISFLqrGFQVTSPEPVAGDESSTTQIIL---
67 UniRef50_Q0VPY1 General secretion pathway p... 104 3e-21 1 17.8% 37:283 120:375 ------------------------------------RWAAEQDVLITSLQVDAERLQGQAPLIAELDENqaDRDRCLVVDAQQRDGVQALFGDSLNEPMVLSGPTaaLRNGSGQELLTGPYAPKQKKGSNtaPWKPLGILAASVFVLALVAIWVQQWRYNQAAEATFADAQTLFENLFPGDKASAALSRQFEGRLARLGGgsGQADFFPLLRPVAQVLKEI---NVDPKRLQYDQRENTLLLDVGAKDYAQLEQLQNAlkQGARASIANYRNSAQGVSARIKV---
68 UniRef50_Q1YQU7 General secretion pathway p... 102 1e-20 1 17.9% 1:285 88:364 VISKQDMREWLRIADNAGVTATAMVPDYLALPFESgaWCEGQFLVRSDTDSGFSAAPdlVRRLLERADIAPRLSISILDAALMPEDLREAADVNDAEIDWQFSDMPMSA-----NLLTDEFKPQTT-EVSASSWLSTAALLVLAIVLGFGYLQLSNVRFEERIAELETQASAGFSNLfgKRAKPDDIRSSGELLMADMFKQRESLQA-PVMKALIASDPIMTNCNCELETLVASDSGVSLGLKNVASG-----KIKATTVPGFKVDQKVA----DGVT-TLTLRK-
69 UniRef50_A5GC15 General secretion pathway p... 102 1e-20 1 15.5% 66:284 224:437 -----------------------------------------------------------------ASADQETSPFPPLPVNGEFAEAFAGDTNSARDLAGAYAVARAIATGDPVNFRSGELAYTAGQAKTRKKLRLSMILAVSFVILLFAEVGLRYYLVKKDVDSLNNSIKTIYREVFPTRKKAVDEVAELRSEIKRLSSGKTSSNLLPILTKLAEAKGDDV-----FEVFEAEISGNQVHLKGDARSIQAVNDFKTRTADALsvEVGEIKSRPDG-SVSFVLR--
70 UniRef50_Q2LVK0 General secretory pathway p... 102 1e-20 1 12.9% 51:283 267:505 --------------------------------------------------TGGGALSATLREDLEKFFKTPVEVVDLLKMKGIPLPGKNRLSWNAPLMNQALALALRGGNGsgFNFNKTEKAVTNARNGMKSQLRWTALMAVILFFALGSNLAAGYYADSRKLRHLKEETTKTFKNCCPEVTRIVDPVRQLQQKIIEARgsRGAEQGSLFLDSWKKAMDTLpaSGIVIRELSYN--QIVLEISGEASDFQAVTRWKGELEknIQMQFGSGTNKDAKKTFKLRM---
71 UniRef50_C0QLU1 Putative general secretion ... 102 2e-20 1 15.3% 107:283 286:475 ----------------------------------------------------------------------------------------------------------QNTSQPVLNFCRERYAEDSILKRHARNIAILLVFTTMAFSAFMFKLHDDIHGLEKKGALLDGASVALFKRNFPQKGRIVDPLMQMKIELEQLKQAPGLGSMENSVAAAPQliSNRIPATIDVETTRFILNPGRILLSGSTANFNDIDKIKGLLekQVEIQSAAADKTGNRVRFKFMI---
72 UniRef50_Q4KD22 General secretion pathway p... 102 2e-20 1 13.2% 4:268 122:378 ---RERLQALGRLLEQAGLKLAGLYPAPYALPAPPPglLDEQLLVRQSATQGSV--QPLVAETLEQLRASASELCWIGEVPALPGQPLP-------APQPLAAQLRWSGTPPSWGLHSGALAGTRAPQG----WGRALGCCALAVAVWVLGLNLYAAREAEQGQRLKAQMSQRVKQVFPELPVVLNPLQQARQQLAARQSGAAADPSQGFAHLLAQAGLAMPFMVGSVQSLEFSGQRLQLQLLPDTPKTADSAWQGALIQAGYSVQAQ------------------
73 UniRef50_B3E7L3 General secretion pathway p... 101 3e-20 1 16.1% 3:276 120:422 --AQGQIADLITTLTEAGAEPEIVTASCllLPPDSSecRQGQLLfrTLNNNSDDLERTLATLELTRDLqlASTSERVIELFPLPDALKTPASQDGLAPLALAAPFAAALAFcpFNLRSGPLAWKQKNRRLLRAFRLPLILACIAAVLLLAEAGTRWYLLSRDITSLNSSIGKIYRESFPNRKKAVDEAAELKAEIRRLEGTSLSPTILPFLRLLTEH-KGVEISGFS--EIDYDGTRFKVKGDGRTS--AAISTLRqlLTAGWQVEQPEITSRPDG----------
74 UniRef50_B8GXS1 Type II secretion pathway p... 101 3e-20 1 14.0% 2:286 110:367 -TARDKLQAWLDMAQTHGLAPQAVIPDYLLLPEAEDGV--------------------LTVGRLGARLALREPSKALSADADLAALLFENREHRYLAGKELDAQLITGARAPVINLLQGRFAVRTTGGRGG--LRRLAILTAAAVLSPLLLMIAQIAHDQWTARALERQATKLAVSLAPQASRYEDA---VGYALSRLAASQSGQGFGDLSASYLSMVE--STPGVTLDTLVY-GEEGAIRSTIVYNNYSDMDQLRLGAKrgLELTEQSTASEGGRISSDLIIRRK
75 UniRef50_A6V157 General secretion pathway p... 101 4e-20 1 17.0% 2:284 103:358 -VRRDWLRERLARLAARHLRPKHIHVDVDCLPG----------------------DPPLALRCAGRWLVSAGSAQRLALDDAGLEDLGPVLPPGLRRSEAPPWPLLAEGARLAIDLRQGEFAAHTAKRI---RWPLLALLAVLAGAAQMGQDIGHRLLLEQRSAELRQDNLALWQQRFPSEGRVVDLTRQVQARLRQ--DGQSPVDLARRLDRLADTWSAGGGATATVRRLDYQAGEG-WSLEVGAPAFADLERLREGLaqGLDVQADSAVRGHDGVSARLQIK--
76 UniRef50_B7RHZ6 Putative uncharacterized pr... 101 4e-20 1 13.8% 1:283 125:395 VVDRNVMQA----AAVAGDTP--VLPEIFALPTPATaiSDGRALVRVSDGTGFVVSVAMLPLIWAQAAKPQ-----IQSYGEALPDTMDARAYDARPPKP-------DPKDLGVDLRQGAFAPKAT--DWTRHIKRAAIIAMIGVIGHLGLIVVDTVALTRIAERERAAAQAAIDTVLPGLIVTADVEPILRR-LAPAAPAPKGSAFLTILGNVSAALLEADN-QISFRRLAFADNPARLTMSVEVPGLDDLQQAERLLRagFVVTSGAATASGGVAEAEFVV---
77 UniRef50_A3VSK9 Putative uncharacterized pr... 101 4e-20 1 14.2% 11:278 118:380 ----------LAYLRELELGPTAITVDHLAIAGEDArlFSETATVAYLSDGAFTVPAEMGADLLALMPLAANADVTAAGGHPPKGGGADRSLPDRDA--LAAYWFGKVMAHRPPNALRGRFRRRTDWRGVGKRVRMPVALSLGVIALWLGGVAIEGMKYQRVADQLYDEAAARFSEAFP-----ATPIRDLSRQASRLGGGATTDRFLPLSSRLAAALESHD--EVQLEGLRY-GQDGELVADLRFPNTAALEQVREDLRTGGIteGETIRREADGSS--------
78 UniRef50_Q7NRH5 Probable general secretion ... 99 2e-19 1 14.6% 7:286 106:388 ------LRRAVAMLKSLGRLCDRIVPecLLSPPPAGGWssDRWLVRAAAPYAASLpqQEQALFASLLSTAMPARLQLCGVDSAEEVLARLPGWQGETARGEACDWRSARRHGGYDFAQGDLAANRYWRDWAPSLKKTGWLLGGLLAAQILLTLGQSGWYAWQKHSLSQQIRAAATPWIGGQAQPGSSALAMTRAVDRLRL-SHGLPARDDLVELMGALAAVSGRELQVRTLEYEAGR--LKLQVAEVPAESLARWRKQLAARQIMLDATSSQPGSK---QLVVARE
79 UniRef50_D0XKE4 General secretion pathway L... 99 2e-19 1 12.4% 1:283 94:371 VVRHARIQGWIALLTEADLDPAILMPDALTLPMPPQgvEGGRCLVRTDTGAGFALPLSALDGAWTA----AGRPRLIPLGDALPATFAEAVGSETLHLGTMGEPV---VVLPPLDLRQGPYA--ATRATSASALRTLALVAGVGVVAHIALLGLDTFLLDRMADRKEAEARTVLQAVAPATTPDEDIVAAADRIVP--GAGSGVRPFTRLLAQTSGALPGAGAVAFN----SATYAPGSLDMGVVVSDAATLDRAVQALTASGLTASGaaSSATNGLNATLKV---
80 UniRef50_D0KWL6 Type II secretory pathway c... 98 2e-19 1 15.2% 2:283 116:411 -VDADVRTRVLDALKDQGLVPQHLVAMADTLPQPEMGEfqEHISVLTGPHEGMALApeQLAEWLPRMTPAPNRVAFHVPLDQPAHWPEGIEFTAQAAPDWAQWHQLWQAGLEQNRALSAITSAKAVNDQQwrRWWQVAAAAGVVLVLLLVAQGIKTAQMNHQAERLQTQITQDFHAALPQITRMVNVRVQLQQALDQ-RVGAHEDTFMPALAAFGSAYQVAKPQDAQLVIKSIRFGEQQLTVELTAQKYAVLQQLLEHLKKNAPAEVKQIDAGVDAGVAHMRI---
81 UniRef50_C6BGG8 General secretion pathway L... 98 3e-19 1 16.3% 15:284 206:475 --------------AVAGVTPATIALDA-APSSDPDAPVAVDITVRTGRAEGYGL--RLLPANVGNWLGIAPAPATLMVSPALREllSADPATATLDWSTWAAGARDALASGEADLCQFDFARGGVAGMDWSLWRLPIALAVLIVVVQLIGMNARWLTLRAEQKRLDTAMRAQLQTAFPNTPVILDPPAQMRRQVEQLrgKSAPEDFLPLADRFAQAATGLAPDA--LLALDYHGRALTVTLK-DGTDTASLRTAARNVGLNMDTAEAPRGAEATVPGSRWTVS--
82 UniRef50_Q48JN5 General secretion pathway p... 97 8e-19 1 14.1% 7:261 114:353 ------LERLSRLLSQSRLSLRGLYPAPYGLPVPAPglRDEHWLLRHSAGQGGV------------HPRLTETPDAHLANGSELHRLDDKGTAGLETS----AGLLLSGPSPGWSLHAGIGAAKVRTSGWTAAW----VCCGLAVGVWALGLNLYAAREAARGQQLRAGMVQRVSQAFPHLPVILNPLQQARQQVAALESGSATGTNSGFEQLVKSAAGALPFLVGSVQRLTYSDGRLQLQLLPDNAQPAVDDTLQRSLAQ-------------------------
83 UniRef50_A3W190 Putative uncharacterized pr... 96 1e-18 1 17.3% 1:283 95:391 ITDAGDRRDWLRALGVFAPQCRAVLPDFLCLPAAPDLwtATGVIARLGPEDGFAAEPDLALALLQEAAR-TGMPRAILRNGPARAEIDTFLTAQNLPIcgVTAPARFAYNELSLDLARDPGAERAEMRGILSRLGLPFALAVLGLAGWIAAAMIETGTLTAQGLAYRQNAERILRQVMIPTGPILDIRSQVAQTMDRARNARSEVETEArlDVLRRAGAVLGNHETTITRVRYQPGAG-LVIDLQITDFAALDALVADLraGTEARVAqiTRENTGVDAVLAM---
84 UniRef50_C5CPK6 General secretion pathway L... 94 4e-18 1 11.7% 2:248 113:372 -CNRIWLRTLVQGLESAGRRVVRIVPEFAPQPADggEAEAPQLTVCDADGVVSLPLAGAGLALAAGLPLDTAVISAEPAVAQAAEHLLERRVPIVQAPQRWLQAARSPWELAQFDLagKKFASVVQTLRYAPEWRAARWGIVALLLTQLIGLNAWAWKERNALEAKRQAVKTMLTRTFPSVKLVVDAPLQMAREVAALQQAVGDVAGSD-LEPMIGALAPHLPPGRTPSAIDYSAGQLRLRGLGLQPS--------------------------------------
85 UniRef50_Q5P1A1 General secretion pathway p... 94 5e-18 1 14.7% 1:286 110:402 VISRARLRTVLAGLAEVGCPPLRAVAELQAVPDAGSRWttGGCILRLDATHAFVADAGALADILAHALLQapEALEVRRAPTAPGSIEPATLAGTVPGLRVEAGAawETPAASADLLHGEFAPSHRGSAGRQALRRPLILAAVAVGVFAAVNLASVLWQRHELDGIEERMRRLFVTAVPDTPAIA-PALQLRRHLDEARSLRGELREDDLLALLSAYTegGSAAPASVRTLDYEAGQLKLTLDAASASG------IGVLEKRF-ASLGYVVRSTGGAAPSLTLSRK
86 UniRef50_Q1NDR4 General secretion pathway L... 90 7e-17 1 12.8% 3:284 116:371 --SRSDMQHWMLWAQNHGLDPDIIVPAPLLIEAPE---------------------QGLGRAMIGGAAVLRGENMALPEDMALPELIADAPMIDVTTGMVEGR-AIAALDRPPLDMRQGDFAKRVRPALDHRALQRIAVWTGMILFLLLATALIWLARQHSEANRLDRESLALAQEVLPNASDAAQAQIEMEGRLAAR--GAGGRAFTAPVAALLSAMQ--DAPGVALTTLSRDAD-GMVRATLASAKAEDINIVLLAlaAGFTITATSSQDPGGRTLAEITVR--
87 UniRef50_C1TK51 Putative uncharacterized pr... 90 8e-17 1 10.9% 18:284 107:383 -----------------GLGRSTIWPLPFAMAAELGGNGAVLCLDEEGISSALFVDGVPVLYRWQSRSRRSVDQELRWLLDYGGkdPSDSVVVDVSEDGERLAVKARETLTAFPSL--GSYSLSRksAIVLETLAKAVGGFSCWFlvFLGAGFLGGLVERKKVDTIRARAEAVYTDAF-GPGKVRDPLSQARGKLAELTDSPDTRSLEDGLRLIVRSWTDPEMGgiSVDTLRYTSDGMELI--GTAEEVSSVQAFQKNlnNDGTVKLGDIQqpGGGLRYSLEVR--
88 UniRef50_B3R7W9 GENERAL SECRETORY PATHWAY L... 90 8e-17 1 9.2% 37:275 227:462 ------------------------------------GTRQWQLTVRTGAHAGYGLL--LGDDALAAWQALAPEGNWYaaDATALAPVPALRQAGRAGWPLWIDGAQACLREPGLDLAQFEFAQGRADRWNLVAWRLPLALAAGLVLVQLIGMNTHWLLLRNEQQRLEAAQAQTLRGAFPQTPTVIDAPLQMRRQVEQLrgRSTPDDFLPLADRFAQAARRLPPDA--LQALEYRGRMLVVTLKPGTDTAGLRSAARQ---AGLQMEEDKAGNAAG-----------
89 UniRef50_B9NIA3 Predicted protein n=3 Tax=c... 90 9e-17 1 10.8% 19:258 634:880 ------------------LAQSALLLDTAA-PAPGELSRLWQLTVRTGPYEGyaLSTWQLLAPAGQWHGDNAALANAPVPALQGKRPPMHASRASETWRIWLAGIEECLQQPQLDLAQFEFAQGRMDRWNVRAWRWPALLVVALLLVQIVGMNVQWLTLRKEAKRLEAAQVDLLHTAFPNVPPVAEPILLMRRQVEQLRTASgpNDFLPLADGFARA--ARDLPPDALLQLEYRAATLYVTLKPGTNTSALQNAVRQA----------------------------
90 UniRef50_Q1JVU7 Fimbrial assembly n=1 Tax=D... 89 2e-16 1 18.9% 100:284 262:453 ---------------------------------------------------------------------------------------------------LPVCAMALATDQPLINFRRGPFTLKSEWAALKKHFYIGGGLLLASLAILAATALHSYQFKTEVAQDYRKQLNQVFRETLPGQTAIVDPVQQLTVELNRLRETGRLVGLDKSTSALarDFSTHTPKDITVDIKTFNYEPENLNVEGVTDSFDSVNRLAGELRKsvRIADAKMGIQGKQVSFRLQIS--
91 UniRef50_A7BVH2 General secretion pathway p... 88 3e-16 1 19.0% 1:153 108:274 VIAHAKMDAALQQLSAVGITPTILLPDILAVPKPEEGwlNDIVLVRTGLQAGFAIESDCLSLALQKALIEHEEMPPLEMVVypLAELQALGIPIIEQigTLAWLAQGVTENKPLNLIQNDYLPQDKILTHLRPWRLTIGLLIFWVDCSLLNNG-------------------------------------------------------------------------------------------------------------------------------------
92 UniRef50_A1WNN8 General secretion pathway L... 88 3e-16 1 14.5% 1:275 119:406 VCDRDWLRENLQALEAAGRRVARVVPEFAPGPTASAgeDAYLVLSGQGADQGVAVLPLSRMALALAQTGSAADQTPVLRAEPAVAALAERTLGQSAGLYT-ASQRALDAARSHWDLAQFDLASSGSRRAMRkrWRAARWGAGLLALTQLAGLNVWAWHERQTLAAKQAAVHAVLTQTFAQVQVVANAPVQMENELARLRQAAGSVSASD-LEPMLAAADAALPAGRLPTAIEYSPGALRLRGLALVPDEAS------ALSGRLQAAGYQASVEDG-----------
93 UniRef50_A9BXP6 General secretion pathway L... 88 3e-16 1 15.1% 2:260 132:409 -CNKAWLHAHLQALESAGRPVGRIVPECPPQATpaVGSPESAWLLATGLSTAAQGMDSLACLPLRTDSADPAMLAALLQaqADPALARAAEALQRPVSLLTDAQRGLAARAQSWDLAQFDLDLGGGSRTRRrqWKAARWGAVLALLAQVVGINAWAWTENRAIAAKQVQVRSTLATSFPRVPVIVDAPVQMQREVATLRQTAgqGDLEPLLAAASRALPAGQLPQAM------DYQDRQLRLKGVSLEAEALEQAQQHLA--------------------------
94 UniRef50_A6VAT3 Probable type II secretion ... 88 4e-16 1 12.6% 3:279 114:378 --EASALAPLEQALQRLRLDVRQVQAAPFLLPLREDGWVA-------GEWDGHLLLRRSLTDAAVHPLPEQGLDELPEDLryWLGERPTWNCATLARTEALDEALRWSGPACPWGLA----LKQPMAGAGRGTWKLPLTCAALALLVWVAGLNLYAGRLAGQGQALQRQGIQRVQQAFPELPVVLDPLRQArrRDAYLAGKADGDAAPGLAALLHGTGEAMPFLAGRLQRLDYRDGELDLAL-LPGPAITDAATWQGELGKHGL--QADASDRGWQVRA-------
95 UniRef50_B1Y326 General secretion pathway L... 88 5e-16 1 13.8% 1:269 118:409 VTDRAWLAIQIELIERTGRAVDRVIcdVQTLASGVGEAGNELAGVTFSSAEGVAcdTQTRPGGLATALLPSPLPAELRCSASPAFVLATEAWLGRPVAVRSQAQRLLAAAHGGWNLRQFDLAPRHRGATLLraWRPARWGLVGLLAAQLIGLNAWAWMQRSELQERRTAMTNLMRSTHPQVRAILDAPLQMQRE-NEALRAAAGRAGDTDLEPMLQAAASAWPDNLAVQTLRYENAQ--LSLGATQLGAEQIERLRSSLqaGWRVEGGA-----------------
96 UniRef50_C4SKM6 General secretion pathway p... 87 6e-16 1 13.2% 2:145 74:211 -VEHELMSCWLKWLDNAGISISLMIPDVLTLPFSEDKCsdSQWLIRNGEYSGFSIKESIFDKilVKDKNLSTNRVNYISEQQKKAHLINF--------CDALSIMAENINKDGVNFLSGKYSRYRERKSG---FFPPLGLLALVF---------------------------------------------------------------------------------------------------------------------------------------------
97 UniRef50_A3ERG6 Putative uncharacterized pr... 87 7e-16 1 12.0% 4:286 132:441 ---RRWLENALSVLAVYGLEPKYILPESfaLPRTNEFLSAPSgtLRNGntDASVCMDLLVASVLMDSTEEAFFWTHPEAARPPGAPVIKSPDPEKQEEERYAAALGRWSARAgpDFRNESLAFRKDRDDLVRHIRTLGGVAFLLLLLSLSDAWIHVRALEARVEKTQAILTDLASQIL-RPAPVVEPLSQLTTRKNELAKQEEILSRGTDIIAILKDIAGGPDPGIPFSMVSLSIGKKSLTLSGKTASFQDVEKIRTALLKTPHIRSLVVQ------SARLDIDRK
98 UniRef50_C6CIM8 Type II secretory pathway c... 87 8e-16 1 15.8% 2:285 116:389 -CSCAWLSAVWDEVQAAGLNVKQILPEWLSLPDAPiaWAEPRWLLRFSKGAGY----WLPAVSVQTLLPHIAAPESVSLYGPPPV---EAVCWAAQHPALSDAQRLAPPERVEVNLLRG--LPGSLHITHIRSWHRYIAAASLGLLAAAILALASGLGMVG----YQIQRDTAFLQAFYAHQSIGDAGAslERLIHDRQQqsGESNFFDRLADYLPLSQRFHDPVIT--RLQFDASQRQLRIDVLLPE-TEVRNLIHTAPANVSVAVHEAQAE--KIHVTLVIRR-
99 UniRef50_A4BDW8 Putative uncharacterized pr... 87 8e-16 1 15.8% 55:282 179:411 ------------------------------------------------------AEQQQLPDDARIKLISESAEGSAKALATEFEATGYVVNWQVQPTrlVDWHDQAEQRQPIGNLMTGPFS-QNQGRPNYQQWLPALVASVAVIALWTTLTVFENQRTAEKIDQTWQASEDVFLQVFGQNKRIQRpvREMRTRVATAGSGASeaNALTILRDISNV-----PESFMLEDFRYNADRSEAFFTldGDAYSQFEALKNTLAQQGYQVEYSANQESDRFRAQFK----
100 UniRef50_Q0ASQ5 General secretion pathway L... 86 1e-15 1 11.7% 2:284 111:404 -VETGLLDEWREALAPLIVRPAFIVPDSLVAAEPGAALtgDAILFAHDPDaaGVMDTALFGSVVQALVKAAGS-GEIAVSRSLGLTGANFRAIGQGGIDLRASALDAERLAALPRLFGDSFASTMDWSSLVRPLRRPLLLAAGLLLAFCLLIGGETIYYRLQAERFETATLAEFDHAMPDFGRAveAERLLRARVERLSGD-GQSAFLQLITALDELVDGND--SVRIDHVRYDPARAALSVGATYSDFSDFDDLNARADqgLRLDDGGARESTAGIEGEFVMR--
101 UniRef50_B2T7P7 General secretion pathway p... 86 2e-15 1 14.3% 41:285 229:473 ----------------------------------------ELAIARGVQGEGLAVPASAVNATLSALAGAAPVSLHMLTEVpaPNSPARLAAYIHGASPLPFEQLARRALECRFDLCQFEFapWRLDRATLRRLRLPVLLAVGALLVAIIGANAQWLMLARQRDAINTQMTELLLNTFPKTTVVLDAPDQMSRQLQQLRVAAgpDDFLPLADGLARSLPPVPVNGIA--ALDYHDRRLDVNFKPEIKLDPDF--AKRLARNGLSGAIDSNT-------GKWTIRN-
102 UniRef50_C7HZE9 General secretion pathway L... 86 2e-15 1 15.4% 2:242 110:364 -VQKAALQQAIADLAQAGQEPEKIVPEAALLAPGDALLqgPRLLWRDLQGEAAWLPLILAADAAAPQALPLPVTPEHLWVQDQAQPQLSWLDLPPgpATLSDAGWMARAAQSPWNLRQFDLAPKHALSRGwpAWRRVGALLGLLAVVQLVGMNAAAFKLSRQESQLRQKLDTTAAEALPGVPAILDARLQVQRALNDARLRTGRPGDGDLDVLMGRA-SVVVPPGIVPTVLKFSPGQLQLSL--------------------------------------------
103 UniRef50_C3K8J6 Putative type II secretion ... 85 2e-15 1 12.7% 11:261 114:324 ----------LTRLAQLPLKLRGLYPAPYALPVGAAALDEGYLLTRDSLQQGAV----------------------------------HPLGLQALDVPLVEATQRWGGPVPAWGLHG------RLNQPSTGGWGRALACVALATAIWTVGLNLYAARQVEEGQRLKASMSQQVRQAFPELPVVLNPLQQARQQLAARQTGAAADPGQRFASLVQLAGNNLPFMVGSVDNLSFEQGRLHVELLADSRNPKAEGEWQAALAQ-------------------------
104 UniRef50_C8PZS0 Putative uncharacterized pr... 85 2e-15 1 14.9% 5:272 114:396 ----ADIHSWINAASLAGIEIVALLPDFLLLPTIDTRidADTQLLKLHTYHGMAV--SFLPLVLTKLPMLETLYLTGFHDETVAQQLASMPNLSIESSELLPTP-IKDPVRHFFN-----FATIKGKTTLAPYAKVIALITVCALLTAFVVDALRWYYYNQAQKQAATLLAQQYAQWFPNEPLSSKLTLQRQLSGKLTTQQSATPSVLQTLSSIQPVLQQY---QLTAKQLNFQNNH--LQLQLLSSSADSLNKAVNDmnKGIKAKLGSVDA--------------
105 UniRef50_A8ZWZ1 Fimbrial assembly family pr... 85 3e-15 1 12.8% 2:283 134:482 -VHKEKVKEWIDGFAGAGLQPEMIVpeALLVETTGGYVtdAQWIRFFSAgaGRSALRDGLRQTLLAYEYETGVAAGLKNVFVTGADSRAGEawEPGLLDMALCplLKKSRKPCINFRKGEFSLAARWLQYRYLFGGTAALAALVLVLGLMGFFYDLYSLNRSIATVDARRQAIFRECFPESAAAPSAEM-MRYEIDRLRESSGLPAGLDRtvDILNDISRLVPQETDVVITRLDAGLNDVSVTGNTDAFQSVDTMKNRLEetVVISSATMDKADKRVHFKLQV---
106 UniRef50_Q1QBS4 Putative uncharacterized pr... 84 5e-15 1 15.7% 3:283 108:419 --AQTDIELWQQSAKLAGMNIVALLPDFLLLPLPEEGadKETVLLRQSLYQGMAV--SYLPLIFERFPHLSEVLIVPAIDDptDNELANRTEIENSIAAGSFTAITanAERHALNFF-----VKSMDSQLSPYLRVAMMVALSALVLQMATDAVQWYQYNEATTATKTEIATQYQSWFPNEPLSTRTKLQVQLEPKLRSDSQAPASHMAVLSRISPLIKQSSLKAQALVM-----QPSALSFTLIAPDRGSLDQFTATlaQGLTAKLEQVnnEQGQFSGQVTV---
107 UniRef50_Q1LHW5 General secretion pathway L... 83 9e-15 1 10.8% 19:258 225:471 ------------------LAQSALLLDTAA-PAPGELSRLWQLTVRTGPYEGyaLSTWQLLAPAGQWHGDNAALANAPVPALQGKRPPMHASRASETWRIWLAGIEECLQQPQLDLAQFEFAQGRMDRWNVRAWRWPALLVVALLLVQIVGMNVQWLTLRKEAKRLEAAQVDLLHTAFPNVPPVAEPILLMRRQVEQLRTASgpNDFLPLADGFARA--ARDLPPDALLQLEYRAATLYVTLKPGTNTSALQNAVRQA----------------------------
108 UniRef50_B4RFJ5 Type II secretion system pr... 83 2e-14 1 14.5% 2:283 113:372 -VARSRMQGWLDLARLHGISPDVVAPDCLLLPEPEgaARIGGALAVRGRRLAFACDPDLAPVLLQDRDPE-----------------------LASDAEAVERLLAQGAGRPAINLLQGEFAPADGRRIAPRDLRRAGVLAALLLASPMALEGAEALRLSFAADRAEAAARQDAAAVLPKGTVVRDPAAQVAARLERLELAAGGGPAGLAARLFAAL---SGIEGAQVESLIVSPD-GALRASITHANYSDMELLGGAlgDGIAFKEEGTRDEAGGIVSEVML---
109 UniRef50_Q1D9F0 Putative general secretion ... 83 2e-14 1 12.0% 44:284 277:522 -------------------------------------------TARTRQQVGAVVltAKLPGIAEQLSRDLNLPVRVLALPaaKAIPAAEQPVAAQAYSLSLRGNAAGVRAPRFNLRRGEFAFKGDFDYMKDKLGLLASFAATLILLLIAFGVVRNSVLARREAQVDAVLCDTTQRILGRCEKDYN------RALNMLAGVESPAAALPRLTalLAEVTGRVPDDMPVKFTRIQIDLSRVILEGETDSSKQIDTLSNAIKNhkDVRQGKvtRDGSKMSFRLDVQ--
110 UniRef50_A5V9H8 General secretion pathway L... 82 2e-14 1 15.8% 2:260 108:343 -VDRDLMAAWVAHVAEAGIADAAIMPDALALPVPEAgeADGRILVRTPDGAGFAAREALFVALWTAAGKPACDEVEAGGEALPIA----------------------------LDLRQGDYARPRQ--GLSRTGRRVAIVAVAGLVAHGAIAAADTVALRSVAAKRGAELTQLLATAAPGRYAGADPraLVAAELLPAGGNAPPGTLLPLLSRASSALAPFG-GAVTIRSMQFDEAGRSLRLDVDLADPAARGNIVNALR--------------------------
111 UniRef50_Q2G4Y8 General secretion pathway L... 82 2e-14 1 11.7% 2:284 111:370 -VSAADMDRWIADLSGLGLDPESIIPAGLVLPRDDDR---------------------LVLGTLGGQLLARTPGVAFAGEEALVMTLGAGLEQVLTEEERIAQSLAAIHAAPPLNLRQGAYAAKRVSVFRTADWLGLARMAAIAALLGLLLMLVWIVKWNIDSSALESRALEMAQARFPAATDIDTAERLLNAELARRGQGGASFAAPAA----ALLEAMRAVPAVRLRDLGYAPD-GTLRFTAAAPRADDVNAVLIAlnEGWKVTVPPALAPdgATVAAITVR--
112 UniRef50_B4WDQ9 General secretion pathway p... 80 9e-14 1 11.3% 2:283 114:368 -VGAGLLEAWIDYLAALGVTPVAVVPDCLILPAPADDALSAAVF-----GTDMGLRGAHFAATVQSDLVEAVAGGRPL--------------IRMDDPETLERLLAAAAAAPAVDLLSG---LERKREVRAGGWRLAAGLAAALVVSPLILTLAVGARDQVAADRAERRTLALITETMPDAARASDP---MEAARRQIAVAPPPGGLASVSAALFAAVEQ--VEGAELDSLSADPGQG-VRATVSYPAFSDLETLRTALAagLSMSDASTVEDGGRVVSEIIV---
113 UniRef50_A6GLQ1 Putative uncharacterized pr... 79 1e-13 1 12.0% 1:266 121:397 VLGKTRARNIVSSCAQQGLKLAGLSCETL---RERTGSEGAAWLSGQDFILVDGIDTPLLTPTAQAAVLKVMLQRRLQQAGAPVIELNNTdtWLSSQVDGAmrASARAPIEPLPRLLNKSLLNADELRKMGMrlRKLLAPAVALLTVAVVGLNVLAFKIESANASIEAQINESYAQALPNTPMVADPLLLIEREKRNLNAGLDTSNAQGASALLHEvlAMEQAPFNSMVDFAWAENTLSVRFNANVSEDQQGAALQKLKARRLDAK--------------------
114 UniRef50_C9YDY6 Putative uncharacterized pr... 79 2e-13 1 15.6% 2:206 70:289 -CQRVWLKNTLSALTGAGHTVRRIAPEW----APSTLSDSPTTLWLTGEAEGAELVWavPPSNTSSGTAPAALPTDAAVYAEPACAALAEQLLHREVTVQHRAQRLQSCTDTDWNLAQGEFATRNAALrqAPAWRPARWAFALLCAVQVAGLNAQAWQARQALSSQRSAIQNVLLTTFPNTTVVVDAPLQMQRAVDALGQSSGPGP--------------------------------------------------------------------------------
115 UniRef50_Q88P00 Type II secretion pathway p... 78 5e-13 1 16.3% 1:270 109:354 VVARQQLDDWRGQCPEWGLQTVRCWAELQLLPSPEPGC-AWQW----QRTPGMSLYKGLAEDGQEHWLA---WPDALGGVPQPPWAVLHRTSLSGNWPTVFA----------PLDTLPGLFDRARKVRSLPAASRQQQRLLAACLVLATVWGGLWLSQQWRQAQLWRSQVIAVTGEQASPRHAAQALKRLRESVLQQQLRTRQLDDLQARLQTWLR-----DNPGLRLQAVRFDGQRWHLRLEGEGSAPPWPD-MAAAAGATVQVQDGQV----------------
116 UniRef50_Q39Q90 General secretion pathway p... 76 1e-12 1 14.6% 66:284 206:419 -----------------------------------------------------------------RLGAPATAEGTPLPVEGSLAAAFGGDEGAARRYGSAWALATAMAQGDAVDFRAGDLAWTKGKEKALRRLRLPLALAALLLFLLGADASIRYLLVKRDLASLDASIGTIYREVFPGRKKGVDEAAEMRAELRKLGSSGGKSQVLETLNRLAMAKGDDILGLYEVEI-----DSGQVRLKGDARSTQAVNDFKNRLAAMLsaEVGQITSKPDG-TVTFTLR--
117 UniRef50_Q221L3 Putative uncharacterized pr... 76 1e-12 1 10.3% 1:252 132:393 VCERAWLRAALQVLEQSGRAVSRIVPEFTPQALTNTLYVTGEADAAY-LVGAAEGSVAVLPLSREAMALLAGSEEKNVVAEPAVVASAEALFQRPVTLQQS-ALRQLQAAQSAWDLAQFDLVTSQSARTWKRWAGAARGLLSalLIINLAGLNAWAWKEKSLLNSQRQAIQAVLTTTFPQVRVVVDAPTQMAREVATLQQASGAPSGRD-LESMLGAFGAVAPVNAVPEAIEYVAGEARLklKLTAEQLTAI----------------------------------
118 UniRef50_Q1GWC6 General secretion pathway L... 74 6e-12 1 10.6% 1:284 115:374 VTTHAAMTGWTGWLAARGLTAAA--------------------IIPAAAALPPPEADSLWSAELGGERIIRSADRAWASDPELDPLIAGNHDVAPLDAEAMREALLLTLAAPPLDLLSGAWKPKRRWAVDPAMLRLAKRLAIALVAVSVAIPIVYALRLTADTSRADDAVVAMATRAGVTASDASAAETEIDRRLATAGGGP--LAFSVPASALYDAM--RDAPGVSLKNLSHRTD-GTLTTTLAAPRVDDINQVLLALQagYRITAQPMAGAGGQQMAHVTIR--
119 UniRef50_Q6MMP1 Putative type 4 fimbrial bi... 73 1e-11 1 15.3% 76:271 423:632 ---------------------------------------------------------------------------RVSVLDQIPNVNFERSAYHGAVCGVALGLAIEgpRNPPLNFLRGEFAknHQLKMFWEKWGSTIKVATAALVVLFVYSSLRESFALSLADRTQEVLKSQAKTVAGLKGRAAsiRKYIraDLKTLASVANMNSALDIAKKINDAAPPKSSITLDIHQMAIQDAQVTLQGYVNSpeMSLLQQALTNVSTDGQVKSGQST---------------
120 UniRef50_D0LLX1 Cell division protein FtsA ... 67 7e-10 1 14.0% 3:260 309:557 --EQQRIHGAISrlGSLGREIRRTLQSC----RAKTGATAQYVLLVGGGSRLGGV-----PSFLAETLGLPVERLSSAHAQALFGDKLAGVGAPVDTACVAAGIAFESAgrPHFDLRQGELAYKADLSFLRERAPALLAAAVILLCFATFNGFAALYKLRRAEASLQTELALETTTLFGEPLDVTATMARIGGAAAGKKSVLPRMTAYDILLEVNNKLPAKGDVTLDVQQL--DIRQGKVTFEATARSSPEIDTVEESLQ--------------------------
121 UniRef50_Q1IB26 Putative type II secretion ... 67 7e-10 1 11.5% 82:263 116:286 ---------------------------------------------------------------------------------AQLVHLQDWLQAGRIRPQGVFTQPAED--RPVVDLGGGLQGPAHSLDVG-----RVVAVWSVAVLVWCLGLNLHAMQLASEGEQLRARMVTQVRTAFPHLPVVLNPLQQTRQQLQSGQGAMGTG----LVALLDGAGKAMPFLAGNVAALDYADGELRITPLAEGRKAPADMAWQTQLAAQG-----------------------
122 UniRef50_C4K9R3 General secretion pathway p... 65 3e-09 1 13.3% 1:271 108:384 VVARSELATLVATCKALGRPLDAVRSALQLAPPASGEWtgATAVLRTGLQAGMALDAD-STDTLAEWLALQLDATPAEARPTRLEVRSTTGTPIPETPALAARIGVELREGPTlnLLHGEFAPAHGGDGWWRQLRRPALLAAGAAGAWLLVQAALVAIDGGEERALRERGERLAAEALPGQP-LLEPRMQLRRAHERALQVHGQLAAGDLLALLDAALEAGAP---QPQALRYEDGRLTLEL----ASAPPADLLVRLDARGLAARAEGSR---------------
123 UniRef50_B8JD40 Fimbrial assembly family pr... 65 3e-09 1 15.8% 107:283 351:526 ----------------------------------------------------------------------------------------------------------QGARAPRLNLRRGELAYTRDFEHLKGKLARLGLYAAAILVLAVVSAGVKVFALSRQEAALDRALCDAEQKILGRC----YPNFEEAQAILRGRGTAAAALPRVSAVDVLGELADRVPAEVPVRFDRIEITRDKLHLEGTTDGAESVDKVVEGLRGsgDARSGSARKRASDGKFEFSI---
124 UniRef50_B4SL36 General secretion pathway L... 64 6e-09 1 12.7% 4:263 114:369 ---QQAIMQAQQLLASCALQLQALYPTPLLLPWQNGQadGEHLLVRCGRDRGVVqdVGAVLQSLAARLQQSGVQAVQWIDSVPSVWPESLPATVVAHELQACGPLPAWSLPLPGRSRQAP--------------RLAVGLAVAALVLAALGLQLQVSRWRSEGEALQQDMARQFSARFPEITDVVDPVLQARRALAVPLPAPPLPPVQRQVATTLQAVPEL---GGQVRGLHYTPGQLELELdiLADDAQRLEQWQQAVQAQG-----------------------
125 UniRef50_C4XH40 Putative uncharacterized pr... 63 1e-08 1 12.9% 29:284 198:476 ----------------------------LPLPEAADAAQQATFLAREAVLTLSALASQPPVGLNLILGGKVDRPQAAAALEAALGVPATSLSALPGWPRLPTGEALPEALALAynFLRGELAPAASRATLRRALLLAGGSALVLAVCAIGAYFSMLWRLDASLTRTRAETEAVIAAAAPDLAPSLTLPQKLsaATRRDQGTGPVGGVLEILAAIHQGLGPDGAAKARRVAL----DESRATIDAVADDYTTVDAVKRRLAagVEIRGAKNNPEKKQVEFQLDLK--
126 UniRef50_A9IRQ2 GspL protein n=1 Tax=Bordet... 61 3e-08 1 12.0% 59:242 120:297 ----------------------------------------------------------ARDALRAAWRRLSSAGLAVQAFYPLQVWSETPEQARPAALDDIRDP-RWRAPGPGWSLALPQLAPRQPSR-----WRGAWAWLAAAAAVWIAGLNLYAAQLRHEATRLRERMEQDVRDALPDIPVVLDPVRQARQARDALRAGQGEAAGNDLLSLARVAVQVLPFAADTVDRLEYGDGILTLRL--------------------------------------------
127 UniRef50_A3SDU1 Putative uncharacterized pr... 60 7e-08 1 14.6% 25:285 95:344 ------------------------LPEYLLIPRPPSDneGNRAVVRCSDGTGFAANVNMLPLLWQRAGR------------PSLRALGEPLGADLPAENLSATPPPPDPIDVAFSFAQ----PRKAAARGLAAWKWAAVAVGSALALHMTIAALNLRALSQIAQTERRAAELAISDILPGMALTREVGPVLAR-LTPAQAVVKESSFLPLLSDISRVLTDAPVG---FRRMAWGASENTLVVLMQSPGLDDLQGIEQTLEagFAVRSGAATAGDGGAEVEMRIAR-
128 UniRef50_UPI00016990A8 hypothetical protein Epers_... 60 1e-07 1 17.3% 110:190 1:81 -------------------------------------------------------------------------------------------------------------PRSLLNLLQDEYRHVDAGVQLLKPWISAAVLLMVFLTLQVTLSVLDFIKIDQENSQLSQQIRQLFHSTFPETKWLVDAKAQ------------------------------------------------------------------------------------------------
129 UniRef50_C4UIB0 General secretion pathway p... 59 1e-07 1 21.1% 2:58 101:161 -INKDVIKYWLRWFYELDINPDFVIPDVLCLPYLKDQWSagNLLVRTGKCSGFSIDKE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
130 UniRef50_Q3BXL8 Type II secretion system pr... 58 3e-07 1 13.5% 2:283 105:358 -VDSVVMQHWLARATQLGFVPDAVVPDCLLLEPGADATVagRWLIR-GAQLACSLEPEAARLLLGDRVPAVP---------------------PVPDPTQSIACFARNAAHVPIDLLQHPFANKAAAEQRRAP-RRLAVLAALLLLSPGVLLLAQTLRYEIGARVLQACAATQL--------GVRDAAAVPAALQARRQAGTATDRLAVQLSTLFGAVD--TLPAAELDQLDYNAAQP-LRATLLHTDDASLQQLSARLaaGWHVDPGSSQVEDGRMRTPLAL---
131 UniRef50_UPI00016990A7 hypothetical protein Epers_... 53 2e-05 1 17.0% 192:285 7:99 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------EQKLKELRTTQSTNQADFFSLFIAPASAIKESRGSKLRGISYRD--GQLDIQLSTREIQAIEALKKRLeeGLAVEIRSANAKGNEVTSHLRITR-
132 UniRef50_A6BC52 General secretion pathway p... 52 2e-05 1 17.2% 2:59 13:74 -VERAWVQTVLQRFASQGLTIKRILPDVLALPVSDdaLIGEQWLIRHSETEGAVVDSAW-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
133 UniRef50_Q2KZM9 Putative general secretion ... 49 3e-04 1 8.0% 57:269 104:312 --------------------------------------------------------DGQVEVAWTPRPALEQACALLAGQGMRLRAIIPPSALGEGQALQARGDPRWRAPSPGWSL-----ELPRQAGNTVSQWRSPLQWAAAAALLWLIGLNLYASHLEAEARALRARMTQRVQQSF-NLPVVLDPLRQAQQGLAALGSGQANSH--DFLSLARDVARLPLPTDDRVKQLNYADQALTLQLFAEEDAARQVAviQQAASLGLKLEQQE-----------------
134 UniRef50_C6HW28 Putative uncharacterized pr... 68 5e-10 1 15.2% 3:284 141:464 --SQEEVARLLTRIEESGLSPRWILPESlpLPVGPERQTAGmcQIREGGPGGSDidRRILDLLLSLAATDLSLPPRFAIDSplPESPLAPLVAQVPPVTRPLGEAasGEELASLTFRKGPLAWQGDRAEIRKGIRSLALLSLVLAGVLVADGSAHLSRMNHRVERAREALDREARMALPGH-AIVMPVEQLTQEKAALDRQRHLLSRGADIIGLMKAITAAPPPGVKVELVSLSISRRFVTLSGKTGSFRNVDAFKSSLAATGLIRDISIQSAgdRKTVTFRMR--
135 UniRef50_Q9RW98 Putative uncharacterized pr... 43 0.013 1 14.3% 114:204 4:89 -----------------------------------------------------------------------------------------------------------------INLLPKEYRRQSQPSVWKYASWAAAGLTAAVLGGWFLSVSGDTNQLRERSAALQQQIDAVA----PQKSRFNDLTAQ-QGELERVTQVATQ----------------------------------------------------------------------------------
consensus/100% ..............................................................................................................................................................................................................................................................................................
consensus/90% ..................................................................................................................shht...............hh..hhhhhhhhhh.hh...h.........t.htt...t.h.t.h............ht..ht.................h................h.h..t...h.h............................................
consensus/80% .............h.........hh.t....s.......t..hhh......s..h....h...h..............................................t..hshhpt.ht.t...t..h..ht..hhhhhhhhhh.hh...h.h..httt.tthptt..t.htphhst...h.s...thttthtthttt.t..th...ht.h..hh.......hth.thphp.t...lphth...t.t.htth.t.htt.h.h....................
consensus/70% ..ttt.ht.hht.htthsht.t.hhs-hhhlP...tt..ttphhht.s..tuh.h..thh..hhtt..........h...t.......t..th.........t.hhtth.ts.hsLhpu.at.ttthtt.ht.hphshhhsshhhhh.hh.hhhthhthppptpthptthtthhpphhPt.thhhs..hphpttltphttststsshh.hht.httsht.....thphptlpapttp.plphphts.shtthpthttthttth.hp.t..t...t.........
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown